Perspective Therapeutics (CATX) Cash & Equivalents (2010 - 2026)
Perspective Therapeutics' Cash & Equivalents came in at $48.49 million for Q2 2026, up 68.1% from $28.85 million a year earlier but down 10.2% from the prior quarter.
Powered by 
Analysis
Perspective Therapeutics (CATX) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Perspective Therapeutics' Cash & Equivalents was $30.63 million, down 50.3% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 66.5% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $61.58 million in FY2024 (+566.6%), $9.24 million in FY2023 (-56.0%), $20.99 million in FY2022 and $63.83 million in FY2021.
- The five-year range for quarterly Cash & Equivalents is $9.24 million (Q4 2023) to $252 million (Q2 2024).
- Year-over-year, Cash & Equivalents increased in three of the last seven quarters, with growth averaging 51.5%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2024 (growth of 789.9%), and the weakest in Q2 2025 (a decline of 88.6%).
- Business Quant data shows CATX's Cash & Equivalents at $53.97 million (Q1 2026), $30.63 million (Q4 2025) and $26.76 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Perspective Therapeutics | 311.46 Mn | 311.46 Mn | - | 48.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.49 Mn |
| Mar 31, 2026 | 53.97 Mn |
| Dec 31, 2025 | 30.63 Mn |
| Sep 30, 2025 | 26.76 Mn |
| Jun 30, 2025 | 28.85 Mn |
| Mar 31, 2025 | 44.41 Mn |
| Dec 31, 2024 | 61.58 Mn |
| Sep 30, 2024 | 226.44 Mn |
| Jun 30, 2024 | 252.00 Mn |
| Mar 31, 2024 | 142.12 Mn |
| Dec 31, 2023 | 9.24 Mn |
| Sep 30, 2023 | 17.98 Mn |
| Jun 30, 2023 | 28.32 Mn |
| Mar 31, 2023 | 36.45 Mn |
| Dec 31, 2022 | 20.99 Mn |
| Sep 30, 2022 | 18.99 Mn |
| Jun 30, 2022 | 55.89 Mn |
| Mar 31, 2022 | 58.90 Mn |
| Dec 31, 2021 | 60.35 Mn |
| Sep 30, 2021 | 61.69 Mn |
API Access
Perspective Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CATX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();